PR Distribution Report [011120192697040069709939700]


v.3.517

REPORT DETAILS
PR Distribution Report ID: 011120192697040069709939700
PR Distribution Campaign ID: 2697040069709939700
Customer: fiorenza@xpressocommunications.com
Email for Contacts: mfiorenza6@gmail.com
Press Release: Medis to Launch an Innovative 4D Flow Module for Clinical Practice link opens in a new window
Press Release language: English
PR released on: Nov 1, 2019
Report started on: Nov 1, 2019
Report last updated on: Nov 29, 2019*

* Frequent updates on your PR distribution report are only done during the active period of your PR campaign. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. You’ll be notified via an email if such an update has been made in future on your PR distribution report.
PR campaign duration:
The campaign duration depends on the PR distribution budget.
(Nov 1 – Nov 29, 2019 ~ 28 days)
Is PR campaign active?
The active period of your PR distribution campaign depends on the PR distribution budget.
No. The active period of your PR distribution campaign is over*.

Extend PR campaign & reach?

* Even if the active period of your PR distribution campaign is over, your press release remains alive and is up and running on EuropaWire and all the places it has been published on, released via, submitted to and appeared on. The active period of your PR distribution campaign depends on the PR distribution budget and can be anything between one week and 30+ days if larger PR distribution budgets are used. During the active period of your PR distribution campaign, EuropaWire uses its news-wire platform and market insights to proactively engage in leveraging some of today’s most sophisticated and precise multi-channel targeting options available online to source and reach out to the audience that might be interested in and engage with your PR message based on your targeting preferences. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
PR report observed period:
The observed period for the PR distribution report depends on the PR distribution campaign duration.
(Nov 1 – Nov 29, 2019 ~ 28 days)*

*The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
Report in progress: No
Report is completed: Yes
PR distribution budget: €299
Total reach: 98,307+ (Nov 1 – Nov 29, 2019 ~ 28 days)
Reach level:
Indicates how optimal your reach is versus the average for the PR distribution budget employed.
Reach level~25%*

* Please note that while this indicator looks into how your reach performed towards the average for the same PR budget, targeting different countries, markets and audiences usually results in significantly different reach level for PR distribution campaigns with the same PR budgets.
TABLE OF CONTENT
1) Where did we publish on, release via and submit to…
2) Who did we target, where and how…
3) Who did we reach out to…
4) Who engaged…
5) Insights…
6) Extend…
WHERE DID WE PUBLISH…
Your press release has been published on, released via, submitted to, and appeared on EuropaWire, the Internet, Web, Search engines, the Blogosphere, News, News aggregators, Social media, etc.
Site URL
EuropaWire: Press release page:

Medis to Launch an Innovative 4D Flow Module for Clinical Practice

Categories:

https://europawire.es/healthcare/
https://europawire.es/netherlands/
https://europawire.es/news/
https://europawire.es/pharma-biotech/
https://europawire.es/technology/

Tags:

https://europawire.es/press-releases-tagged-with/4d/
https://europawire.es/press-releases-tagged-with/4d-flow/
https://europawire.es/press-releases-tagged-with/4d-flow-module/
https://europawire.es/press-releases-tagged-with/cardiologists/
https://europawire.es/press-releases-tagged-with/cardiology/
https://europawire.es/press-releases-tagged-with/cardiovascular/
https://europawire.es/press-releases-tagged-with/cardiovascular-diagnosis/
https://europawire.es/press-releases-tagged-with/cardiovascular-imaging-technology/
https://europawire.es/press-releases-tagged-with/clinical/
https://europawire.es/press-releases-tagged-with/clinical-researchers/
https://europawire.es/press-releases-tagged-with/clinicians/
https://europawire.es/press-releases-tagged-with/cprs/
https://europawire.es/press-releases-tagged-with/curved-planar-reformats/
https://europawire.es/press-releases-tagged-with/fiorenza-mella/
https://europawire.es/press-releases-tagged-with/gui/
https://europawire.es/press-releases-tagged-with/heart/
https://europawire.es/press-releases-tagged-with/heartmri/
https://europawire.es/press-releases-tagged-with/imaging/
https://europawire.es/press-releases-tagged-with/imaging-research/
https://europawire.es/press-releases-tagged-with/leiden-university-medical-center/
https://europawire.es/press-releases-tagged-with/medis/
https://europawire.es/press-releases-tagged-with/medis-suite-autoq/
https://europawire.es/press-releases-tagged-with/medis-suite-mr/
https://europawire.es/press-releases-tagged-with/module/
https://europawire.es/press-releases-tagged-with/mri/
https://europawire.es/press-releases-tagged-with/pediatric/
https://europawire.es/press-releases-tagged-with/radiologists/
https://europawire.es/press-releases-tagged-with/scan/
https://europawire.es/press-releases-tagged-with/software/
https://europawire.es/press-releases-tagged-with/technology-2/

Google: https://www.google.com/search?hl=en&noj=1
Google News: https://www.google.com/search?q=
Bing News: https://www.bing.com/news/search?q=…
Apple News:
(To view this channel open the link on an iPad, iPhone, or iPod touch with iOS 9 or later and Apple News)
https://apple.news/TgIdasElxRICK2SON_8eNPw
Yahoo Search: http://search.yahoo.com/search?…
Bing Search: http://www.bing.com/search?…
Blogosphere: http://www.blogsearchengine.org/search.html?cx=
Twitter: https://twitter.com/europawire

Medis to Launch an Innovative #4D Flow Module for Clinical Practice https://europawire.es/medis-to-launch-an-innovative-4d-flow-module-for-clinical-practice-39700/eu-press-release/2019/11/01/ #cardiology #radiology #imaging #heart #MRI @MedisNL

https://twitter.com/europawire/status/1190317541228515328
https://twitter.com/hashtag/4D?src=hash
https://t.co/d27BHg8M2R
https://twitter.com/hashtag/cardiology?src=hash
https://twitter.com/hashtag/radiology?src=hash
https://twitter.com/hashtag/imaging?src=hash
https://twitter.com/hashtag/heart?src=hash
https://twitter.com/hashtag/MRI?src=hash
https://twitter.com/MedisNL
https://t.co/6ctdPc4F0p
https://pbs.twimg.com/media/EITbeiKWoAAYbf5.jpg
https://twitter.com/AndSansi
https://pbs.twimg.com/profile_images/1092913500828127232/8g_CDWRL_normal.jpg
https://twitter.com/mariokun21
https://pbs.twimg.com/profile_images/1188388303017512962/gmhFaKz1_normal.jpg
https://twitter.com/fredykoglin
https://pbs.twimg.com/profile_images/1181855795207659520/O4_gXctQ_normal.jpg
https://twitter.com/Acu4D
https://pbs.twimg.com/profile_images/1197562895258849280/HQ6388Cu_normal.jpg
https://twitter.com/Only4You4ever
https://pbs.twimg.com/profile_images/1161414963568742401/1MFNqp_R_normal.jpg
https://twitter.com/lucy_perezc
https://pbs.twimg.com/profile_images/1188586987755843584/Yo6g39X1_normal.jpg
https://twitter.com/eprnetwork
https://pbs.twimg.com/profile_images/876376260590669825/zlGcMv1K_normal.jpg
https://twitter.com/MargittaLiebsc2
https://pbs.twimg.com/profile_images/1159499627990847497/J57gsIUy_normal.jpg
https://twitter.com/europawire
https://pbs.twimg.com/profile_images/3534828639/c0182e5d73d29df7db4f85a87e3e42c4_normal.png

Innovative #cardiovascular #imaging technology solutions developer @MedisNL today announced a new module for the company’s Medis Suite MR https://europawire.es/medis-to-launch-an-innovative-4d-flow-module-for-clinical-practice-39700/eu-press-release/2019/11/01/

https://twitter.com/europawire/status/1190319843809136641
https://twitter.com/hashtag/cardiovascular?src=hash
https://twitter.com/hashtag/imaging?src=hash
https://twitter.com/MedisNL
https://t.co/d27BHg8M2R
https://t.co/sLsKGXL1EB
https://pbs.twimg.com/media/EITdk9WX0AEHnxQ.png
https://pbs.twimg.com/media/EITdk9dWwAUj036.jpg
https://twitter.com/JungKook_euphor
https://pbs.twimg.com/profile_images/1190879365854375941/avyOH2Q2_normal.jpg
https://twitter.com/mariokun21
https://pbs.twimg.com/profile_images/1188388303017512962/gmhFaKz1_normal.jpg
https://twitter.com/Nikol48385054
https://pbs.twimg.com/profile_images/1175180583749718017/AbjA7j0J_normal.jpg
https://twitter.com/DavidRana04
https://pbs.twimg.com/profile_images/1041788829139718147/OXgF_srV_normal.jpg
https://twitter.com/_biaapereiraa_
https://pbs.twimg.com/profile_images/1191685567404290048/UXacsaKx_normal.jpg
https://twitter.com/_NiallHmylife_
https://pbs.twimg.com/profile_images/1177647923267608578/msHY5T49_normal.jpg
https://twitter.com/Oni_2018
https://pbs.twimg.com/profile_images/1191571858501652480/oMv_glpX_normal.jpg
https://twitter.com/AndreaTumba5
https://pbs.twimg.com/profile_images/1162308306519674880/h3DkwxsB_normal.jpg
https://twitter.com/DrippyMartial
https://pbs.twimg.com/profile_images/1180962169950744576/SQcNiCaF_normal.jpg

Hans Brons, Medis: With the help of this new module for Medis Suite MR, it is now possible to acquire flow in #4D from a single #scan and to create flow plane reconstructions retrospectively https://europawire.es/medis-to-launch-an-innovative-4d-flow-module-for-clinical-practice-39700/eu-press-release/2019/11/01/ #healthcare @MedisNL

https://twitter.com/europawire/status/1190325547483770882
https://twitter.com/hashtag/4D?src=hash
https://twitter.com/hashtag/scan?src=hash
https://t.co/d27BHg8M2R
https://twitter.com/hashtag/healthcare?src=hash
https://twitter.com/MedisNL
https://t.co/ghbIVry68f
https://pbs.twimg.com/media/EITixPPXsAAruyk.png
https://pbs.twimg.com/media/EITixPSXsAIWTa1.png
https://twitter.com/DavidRana04
https://pbs.twimg.com/profile_images/1041788829139718147/OXgF_srV_normal.jpg
https://twitter.com/ahmed_elbavi
https://pbs.twimg.com/profile_images/1169796957709225987/k1LuEbQ9_normal.jpg
https://twitter.com/_NiallHmylife_
https://pbs.twimg.com/profile_images/1177647923267608578/msHY5T49_normal.jpg
https://twitter.com/AndreaTumba5
https://pbs.twimg.com/profile_images/1162308306519674880/h3DkwxsB_normal.jpg
https://twitter.com/JungKook_euphor
https://pbs.twimg.com/profile_images/1190879365854375941/avyOH2Q2_normal.jpg
https://twitter.com/mariokun21
https://pbs.twimg.com/profile_images/1188388303017512962/gmhFaKz1_normal.jpg
https://twitter.com/hoseokpijesokxd
https://pbs.twimg.com/profile_images/1199615922815811584/tmQuygBt_normal.jpg
https://twitter.com/AmirhosseinNo10
https://pbs.twimg.com/profile_images/1134537133581045760/TIqtaSa2_normal.png
https://twitter.com/fancesc39282227
https://pbs.twimg.com/profile_images/1096082777513095168/chqu5050_normal.jpg

Hans Brons, Medis: The new #4D Flow Module allows the complexity of #HeartMRI scans to be reduced substantially https://europawire.es/medis-to-launch-an-innovative-4d-flow-module-for-clinical-practice-39700/eu-press-release/2019/11/01/ #cardiology #radiology #imaging

https://twitter.com/europawire/status/1190326505307607045
https://twitter.com/hashtag/4D?src=hash
https://twitter.com/hashtag/HeartMRI?src=hash
https://t.co/d27BHg8M2R
https://twitter.com/hashtag/cardiology?src=hash
https://twitter.com/hashtag/radiology?src=hash
https://twitter.com/hashtag/imaging?src=hash
https://t.co/h5MNFWKt2o
https://pbs.twimg.com/media/EITjojZX0AEGVJR.jpg
https://pbs.twimg.com/media/EITjojuWwAcgqpk.png
https://twitter.com/Acu4D
https://pbs.twimg.com/profile_images/1197562895258849280/HQ6388Cu_normal.jpg
https://twitter.com/RolandAron3
https://pbs.twimg.com/profile_images/1094128487353458689/5jD-e2W4_normal.jpg
https://twitter.com/balutescumariu1
https://pbs.twimg.com/profile_images/850077892470087684/CGXi_Rgh_normal.jpg
https://twitter.com/fancesc39282227
https://pbs.twimg.com/profile_images/1096082777513095168/chqu5050_normal.jpg
https://twitter.com/_biaapereiraa_
https://pbs.twimg.com/profile_images/1191685567404290048/UXacsaKx_normal.jpg
https://twitter.com/mariokun21
https://pbs.twimg.com/profile_images/1188388303017512962/gmhFaKz1_normal.jpg
https://twitter.com/GoncaloPinto4
https://pbs.twimg.com/profile_images/1185644075598385152/7W4J6KqJ_normal.jpg
https://twitter.com/_sunjeon_
https://pbs.twimg.com/profile_images/1192837009401888768/fR3cHRSN_normal.jpg
https://twitter.com/malikmchalik65
https://pbs.twimg.com/profile_images/1191053866781020160/dKUFqQzw_normal.jpg

Medis: Based on over 15 years of experience with cardiac MR, and over 30 years of cardiovascular medical image analysis in general, Medis Suite MR is a vendor-independent post-processing solution for #HeartMRI cases https://europawire.es/medis-to-launch-an-innovative-4d-flow-module-for-clinical-practice-39700/eu-press-release/2019/11/01/

https://twitter.com/europawire/status/1190334381854011397
https://twitter.com/hashtag/HeartMRI?src=hash
https://t.co/d27BHg8M2R
https://t.co/BcuxV5mhjB
https://pbs.twimg.com/media/EITqzQZWoAEMd2J.jpg
https://pbs.twimg.com/media/EITqzQgWkAAknJD.png
https://twitter.com/mariokun21
https://pbs.twimg.com/profile_images/1188388303017512962/gmhFaKz1_normal.jpg
https://twitter.com/DOBLEPUM_
https://pbs.twimg.com/profile_images/1191827760714600448/Ax5Wzom5_normal.png
https://twitter.com/Martina11632708
https://pbs.twimg.com/profile_images/1199466739064549377/DCHTNB_q_normal.jpg
https://twitter.com/_NiallHmylife_
https://pbs.twimg.com/profile_images/1177647923267608578/msHY5T49_normal.jpg
https://twitter.com/MargittaLiebsc2
https://pbs.twimg.com/profile_images/1159499627990847497/J57gsIUy_normal.jpg
https://twitter.com/eprnetwork
https://pbs.twimg.com/profile_images/876376260590669825/zlGcMv1K_normal.jpg
https://twitter.com/europawire
https://pbs.twimg.com/profile_images/3534828639/c0182e5d73d29df7db4f85a87e3e42c4_normal.png
https://twitter.com/MiramMiran
https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png

MEDIS: THE NEW 4D FLOW MODULE REDUCES THE COMPLEXITY OF HEARTMRI SCANS SUBSTANTIALLY https://eprhealthcarenews.com/2019/11/04/medis-the-new-4d-flow-module-reduces-the-complexity-of-heartmri-scans-substantially/ #cardiology #radiology #imaging #4D #heart #MRI

https://twitter.com/eprnetwork/status/1191384667418714113
https://t.co/qzwzA874dl
https://twitter.com/hashtag/cardiology?src=hash
https://twitter.com/hashtag/radiology?src=hash
https://twitter.com/hashtag/imaging?src=hash
https://twitter.com/hashtag/4D?src=hash
https://twitter.com/hashtag/heart?src=hash
https://twitter.com/hashtag/MRI?src=hash
https://t.co/Vqs2eYKE82
https://pbs.twimg.com/media/EIimCLsX0AcVJsL.jpg

Facebook: https://www.facebook.com/EuropaWire

MEDIS TO LAUNCH AN INNOVATIVE #4D FLOW MODULE FOR CLINICAL PRACTICE

https://www.facebook.com/EuropaWire/posts/1868183946660388
https://www.facebook.com/hashtag/4d
https://www.facebook.com/hashtag/cardiology
https://www.facebook.com/hashtag/radiology
https://www.facebook.com/hashtag/imaging
https://www.facebook.com/hashtag/heart
https://www.facebook.com/hashtag/mri
https://www.facebook.com/UniversiteitLeiden
https://www.facebook.com/EuropaWire/photos/a.450468198431977/1868183859993730

INNOVATIVE #CARDIOVASCULAR #IMAGING TECHNOLOGY SOLUTIONS DEVELOPER @MEDISNL TODAY ANNOUNCED A NEW MODULE FOR THE COMPANY’S MEDIS SUITE MR

https://www.facebook.com/EuropaWire/posts/1868185516660231
https://www.facebook.com/hashtag/4d
https://www.facebook.com/hashtag/cardiology
https://www.facebook.com/hashtag/radiology
https://www.facebook.com/hashtag/imaging
https://www.facebook.com/hashtag/heart
https://www.facebook.com/hashtag/mri
https://www.facebook.com/UniversiteitLeiden
https://www.facebook.com/EuropaWire/photos/a.450468198431977/1868183859993730

HANS BRONS, MEDIS: WITH THE HELP OF THIS NEW MODULE FOR MEDIS SUITE MR, IT IS NOW POSSIBLE TO ACQUIRE FLOW IN #4D FROM A SINGLE #SCAN AND TO CREATE FLOW PLANE RECONSTRUCTIONS RETROSPECTIVELY

https://www.facebook.com/EuropaWire/posts/1868187183326731
https://www.facebook.com/hashtag/4d
https://www.facebook.com/hashtag/cardiology
https://www.facebook.com/hashtag/radiology
https://www.facebook.com/hashtag/imaging
https://www.facebook.com/hashtag/heart
https://www.facebook.com/hashtag/mri
https://www.facebook.com/UniversiteitLeiden
https://www.facebook.com/EuropaWire/photos/a.450468198431977/1868183859993730

HANS BRONS, MEDIS: THE NEW #4D FLOW MODULE ALLOWS THE COMPLEXITY OF #HEARTMRI SCANS TO BE REDUCED SUBSTANTIALLY

https://www.facebook.com/EuropaWire/posts/1868188426659940
https://www.facebook.com/hashtag/4d
https://www.facebook.com/hashtag/cardiology
https://www.facebook.com/hashtag/radiology
https://www.facebook.com/hashtag/imaging
https://www.facebook.com/hashtag/heart
https://www.facebook.com/hashtag/mri
https://www.facebook.com/UniversiteitLeiden
https://www.facebook.com/EuropaWire/photos/a.450468198431977/1868183859993730

MEDIS: BASED ON OVER 15 YEARS OF EXPERIENCE WITH CARDIAC MR, AND OVER 30 YEARS OF CARDIOVASCULAR MEDICAL IMAGE ANALYSIS IN GENERAL, MEDIS SUITE MR IS A VENDOR-INDEPENDENT POST-PROCESSING SOLUTION FOR #HEARTMRI CASES

https://www.facebook.com/EuropaWire/posts/1868189953326454
https://www.facebook.com/hashtag/4d
https://www.facebook.com/hashtag/cardiology
https://www.facebook.com/hashtag/radiology
https://www.facebook.com/hashtag/imaging
https://www.facebook.com/hashtag/heart
https://www.facebook.com/hashtag/mri
https://www.facebook.com/UniversiteitLeiden
https://www.facebook.com/EuropaWire/photos/a.450468198431977/1868183859993730

Instagram: N/A
G+ https://plus.google.com/+EuropaWire

Google+ (Google Plus) social network has been discontinued for consumers as of April 2, 2019

Pinterest: https://www.pinterest.com/europawire

https://www.pinterest.com/europawire/healthcare/
https://www.pinterest.com/europawire/pharma-biotech/
https://www.pinterest.com/europawire/technology/
https://www.pinterest.com/pin/399413060704101841/
https://www.pinterest.com/pin/399413060704101845/
https://www.pinterest.com/pin/399413060704101848/

Flipboard: https://flipboard.com/@europawire

https://flipboard.com/@europawire/europawire-t5lr53afy
https://flipboard.com/@europawire/healthcare-vkgkndpcy
https://flipboard.com/@europawire/pharma-%26-biotech-t3albt3dy
https://flipboard.com/@europawire/technology-nae4rbdey

crunchbase: https://www.crunchbase.com/organization/medis-medical-imaging-systems-bv
https://www.crunchbase.com/person/johan-h-c-reiber
https://www.crunchbase.com/person/sebastiaan-kole
Paper.li: https://paper.li/e-1431004197
EPR HEALTHCARE NEWS: https://www.eprhealthcarenews.com/2019/11/04/medis-the-new-4d-flow-module-reduces-the-complexity-of-heartmri-scans-substantially/
https://www.eprhealthcarenews.com/category/cardiology/
https://www.eprhealthcarenews.com/category/healthcare/
https://www.eprhealthcarenews.com/category/healthcare-software/
https://www.eprhealthcarenews.com/tag/4d/
https://www.eprhealthcarenews.com/tag/4d-flow/
https://www.eprhealthcarenews.com/tag/4d-flow-module/
https://www.eprhealthcarenews.com/tag/cardiologists/
https://www.eprhealthcarenews.com/tag/cardiology/
https://www.eprhealthcarenews.com/tag/cardiovascular/
https://www.eprhealthcarenews.com/tag/cardiovascular-diagnosis/
https://www.eprhealthcarenews.com/tag/cardiovascular-imaging-technology/
https://www.eprhealthcarenews.com/tag/clinical/
https://www.eprhealthcarenews.com/tag/clinical-researchers/
https://www.eprhealthcarenews.com/tag/clinicians/
https://www.eprhealthcarenews.com/tag/cprs/
https://www.eprhealthcarenews.com/tag/curved-planar-reformats/
https://www.eprhealthcarenews.com/tag/fiorenza-mella/
https://www.eprhealthcarenews.com/tag/gui/
https://www.eprhealthcarenews.com/tag/heart/
https://www.eprhealthcarenews.com/tag/heartmri/
https://www.eprhealthcarenews.com/tag/imaging/
https://www.eprhealthcarenews.com/tag/imaging-research/
https://www.eprhealthcarenews.com/tag/leiden-university-medical-center/
https://www.eprhealthcarenews.com/tag/medis/
https://www.eprhealthcarenews.com/tag/medis-suite-autoq/
https://www.eprhealthcarenews.com/tag/medis-suite-mr/
https://www.eprhealthcarenews.com/tag/module/
https://www.eprhealthcarenews.com/tag/mri/
https://www.eprhealthcarenews.com/tag/pediatric/
https://www.eprhealthcarenews.com/tag/radiologists/
https://www.eprhealthcarenews.com/tag/scan/
https://www.eprhealthcarenews.com/tag/software/
https://www.eprhealthcarenews.com/tag/technology/
https://www.eprhealthcarenews.com/tag/technology-cardiology/
WHO DID WE TARGET…
Countries, markets, verticals, audiences, interests, industries, categories, keywords, tags, etc.
Countries: Germany (EU)
France (EU)
United Kingdom (EU)
Italy (EU)
Spain (EU)
Netherlands (EU)
Sweden (EU)
Poland (EU)
Belgium (EU)
Austria (EU)
Denmark (EU)
Finland (EU)
Greece (EU)
Portugal (EU)
Ireland (EU)
Czech Republic (EU)
Croatia (EU)
Luxembourg (EU)
Bulgaria (EU)
Slovenia (EU)
Russia
Switzerland
Norway
Monaco
San Marino
Language: English
Regions, Metros, DMAs, Cities, Towns, etc.: Rome, Milan, Amsterdam. Rotterdam, Leiden, Zurich, Basel, Cologne, Frankfurt, Brussels, Copenhagen, Oslo, Warsaw, Moscow, Porto, Lisbon, Monaco, Barcelona, Madrid, Vienna, Paris, Stockholm, Valletta, London, Sarajevo, Minsk, Tallinn (The countries those cities belong to were not targeted)
Industries: Healthcare, Pharma & Biotech, Technology, Science, etc.
Markets / Verticals: Cardiology, radiology, imaging, 4D, heart, MRI, etc.
Audiences: Internet, search engines and social media users living/residing in Germany (EU), France (EU), United Kingdom (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Portugal (EU), Ireland (EU), Hungary (EU), Luxembourg (EU), Slovenia (EU), Estonia (EU), Malta (EU), Russia, Switzerland, Norway, Iceland, Monaco, San Marino, Bosnia and Herzegovina, Belarus, Spain (EU), Sweden (EU) using English language and with identified interests like Healthcare, Pharma & Biotech, Science, cardiology, cardiovascular, radiology, imaging, 4D, heart, MRI, pediatric, etc.
Age: 22-65
Gender: All
Interests: Healthcare, Pharma & Biotech, Science, cardiology, cardiovascular, radiology, imaging, 4D, heart, MRI, pediatric, etc.
Categories, Keywords, Tags: Healthcare, Pharma & Biotech, Science, Technology, 4D, 4D flow, 4D Flow module, cardiologists, cardiology, cardiovascular, cardiovascular diagnosis, cardiovascular imaging technology, Clinical, clinical researchers, Clinicians, CPRs, curved planar reformats, Fiorenza Mella, GUI, Heart, HeartMRI, imaging, imaging research, Leiden University Medical Center, Medis, Medis Suite AutoQ, Medis Suite MR, module, MRI, pediatric, Radiologists, scan, software, technology, etc.
Platforms: Desktop, mobile
WHO DID WE REACH OUT TO…
Total targeted reach, social media reach, followers, subscribers, etc.
Total generic reach: 44,209 people (Nov 1 – Nov 29, 2019 ~ 28 days)
Total generic video views: 0 people (Nov 1 – Nov 29, 2019 ~ 28 days)
Total targeted reach: 54,098 people (Nov 1 – Nov 29, 2019 ~ 28 days)
Total targeted video views: 0 people (Nov 1 – Nov 29, 2019 ~ 28 days)
Total reach:
(generic + targeted)
98,307 people (Nov 1 – Nov 29, 2019 ~ 28 days)
Cost per PR total reach: €0.0030
Who did we reach: 54,098+ internet, search engines and social media users living/residing in Germany (EU), France (EU), United Kingdom (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Portugal (EU), Ireland (EU), Hungary (EU), Luxembourg (EU), Slovenia (EU), Estonia (EU), Malta (EU), Russia, Switzerland, Norway, Iceland, Monaco, San Marino, Bosnia and Herzegovina, Belarus, Spain (EU), Sweden (EU) using English language and with identified interests like Healthcare, Pharma & Biotech, Science, cardiology, cardiovascular, radiology, imaging, 4D, heart, MRI, pediatric, etc.
Combined number of followers the PR reached out to:
(Twitter, FB, G+, incl. re-tweets, likes, shares, etc.)
226,587+
Cost per follower reach: €0.0013
High profile European influencers reached: 200+

(European/EU politicians, policy makers, government leaders, environmentalists, industrialists, bankers, financiers, c-level execs, top-level managers, professionals, consultants, analysts, investors, high networth individuals, etc.)
Cost per influencer reach: €1.495
Related accounts reached out with your PR message:
(This may also include entities, individuals, accounts, etc. associated with your press release)
MEDIS

@MedisNL
@medisnl (YT)
@medis-medical-imaging-systems-bv (LI)

HANS BRONS

@hans-brons (LI)

LEIDEN UNIVERSITY MEDICAL CENTER

@unileidennews (TW)
@UniversiteitLeiden (FB)
@UniversiteitLeiden (YT)
@leiden-university (LI)
@universiteitleiden (IG)

Relevant entities, media outlets, editorial desks, journalists, bloggers, influencers, social media accounts, etc. reached out with your PR message: ENGLISH LANGUAGE MARKETS (EUROPE)

BBC Health News
The BMJ
The Lancet
Guardian Healthcare
Univadis UK
PulseToday
GPonline.com
HealthServiceJournal
Irish Medical News
Irish Medical Times
Medical Independent

@bbchealth
@bmj_latest
@bmjdotcom (FB)
@TheLancet
@GdnHealthcare
@univadisUK
@pulsetoday
@PulseToday.co.uk (FB)
@GPonlinenews
@HSJnews
@HSJ.community (FB)
@IMN_doctors
@IMT_latest
@IrishMedicalTimes (FB)
@med_indonews

FRENCH LANGUAGE MARKETS (EUROPE)

Egora.fr
JIM.fr
LeQuotidienduMédecin
Le Figaro Santé
Allodocteurs
APMnews.com
HOSPIMEDIA
AP-HP
Le Généraliste
Univadis France
Informations Médicales (BE)

@Egorafr
@egorafr-130520827015604/
@jimweb
@leQdM
@LeFigaro_Sante
@Allodocteurs
@APMinfos
@HOSPIMEDIA
@APHP
@LeGene_hebdo
@univadisFR

GERMAN LANGUAGE MARKETS (EUROPE)

Deutsches Ärzteblatt
Ärzte Zeitung
SPIEGEL ONLINE Gesundheit
FOCUS Gesundheit
SZ Gesundheit
SpringerMedizin.de
Medical Tribune
ots | Gesundheit
MEDIZIN ASPEKTE
deutsche-gesundheits-nachrichten.de
gesundheit.de
PA_Gesundheit
univadis.de
medonline.at (Medizin Medien Austria)
pharmainside.at
MEDIZIN populär (AT)
Medical Tribune (CH)
Schweizerische Ärztezeitung (CH)
Swiss Medical Weekly (CH)
Swiss Medical Forum (CH)
EMH Schweizerischer Ärzteverlag (CH)

@Dt_Aerzteblatt
@aerzteblatt (FB)
@aerztezeitung
@SPIEGEL_Gesund
@focusgesundheit
@SZ_Gesundheit
@SpringerMedizin
@MedTrib_medizin
@ots_gesundheit
@medizinaspekte
@gesundheitd
@gesundheit.de (FB)
@gesundheit-de-701 (xing)
@PA_Gesundheit
@univadis_de
@medonline.at (FB)
@medizinmedienaustria (xing)
@medizinpopulaer (FB)
@MedTribCH
@medicaltribune.ch (FB)
@saez.ch (FB)
@SwissMedicalWeekly (FB)
@SwissMedWkly
@emhmedia (FB)

ITALIAN LANGUAGE MARKETS (EUROPE)

Corriere.it Salute
adnkronos.com/Salute
Sole 24 Ore Sanità
Quotidiano Sanità
24salute
MSD Salute
Doctor33
MedicalExcellence.TV
med observer
Saluteuropa
Medicina Moderna
La Nostra Salute

@Corriere_Salute
@adnk_salute
@24OreSanita
@QSanit
@24salute
@msdsalute
@DoctorNews33
@MedexTV
@medlookout
@Saluteuropa
@MedicinaModerna
@LaNostraSalute

NORDIC LANGUAGES MARKETS (EUROPE)

SE

Läkartidningen
Sjukhusläkaren
Läkarförbundet
Dagens Medicin
Vårdfokus
Sjukhusläkarna
DOKTORN.com

@lakartidn
@Sjukhuslakaren
@sjukhuslakaren (FB)
@lakarforbundet
@dagensmedicin
@Vardfokus
@sjukhuslakarna
@doktornpunktcom

DUTCH LANGUAGES MARKETS (EUROPE)

NL

Pharmaceutisch Weekblad (PW)
Farma Actueel
FarmaMagazine
Apothekersnieuws.nl
Apotheek
De Vereniging Innovatieve Geneesmiddelen
De Stichting Farmaceutische Kengetallen (SFK)
De Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie | KNMP
Farma Tweets
Stichting Bedrijfsfonds Apotheken (SBA)
Artsenfederatie KNMG
Medisch Contact
V&VN
Aliëtte Jonkers

@PWnieuws
@farmaactueel
@FarmaMagazine
@Apothekernieuws
@Apothekers
@wewordenbeter
@SFKnieuws
@KNMP
@FarmaTweets
@SBAapotheek
@KNMG
@medischcontact
@VenVN
@aliettejonkers



(When targeting is too broad — too many countries, audiences, industries and markets are sought after — while the PR budget allocated does not provide the necessary reach and duration of the PR distribution campaign, it becomes nearly impossible to identify the relevant entities to reach out to with your PR message.)

WHO ENGAGED…
PR title views and displays, PR reads, engagements, social media insights, analytics and metrics, mentions, interactions, likes, tweets/retweets, shares, comments, replies, etc.
PR title views/displays:
(generic + targeted)
98,307+ people
PR video views:
(generic + targeted)
0 people
Cost per PR title view: €0.0030
Cost per PR video view: €0.00
PR total reads: 7,732* precisely targeted people read*** your press release
(Nov 1 – Nov 29, 2019 ~ 28 days**)

* The total PR reads number above is not final. It only covers the observed period for the PR distribution report, which is the active period of your PR campaign, which on itself depends on the PR distribution budget employed. The total number of people who will read your press release is highly likely to increase over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

** The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.

*** Read definition: For the sake of the metrics the read is considered and only counted as such, if the following conditions are met: 1) The press release page has fully been loaded in the browser and the time spent on the page by the visitor is at least 30 seconds; 2) An IP address is only counted once per 24 hours regardless how many times the same IP returned on the press release content; 3) Press release content viewed on social media sites do count as reads if and only when there are clear engagements (e.g. likes/loves, shares, tweets, re-tweets, etc.) reported by the respective social media accounts’ metrics and we have an access to and control over those accounts the event/engagement happened on in order to confirm/vitrify; 4) PR title viewed as well as PR title + excerpts viewed, either on the site or on social media accounts and third party sites and places, do NOT count as reads for the purpose of this report; 5) In general and by default press release reads are always more than what we can duly report in our press release distribution reports as we CANNOT gather data for press release content views, reads, shares, mentions, references, etc., on third party sites, social media accounts, private emails and communications (messengers, etc.) that are beyond our control and we have no access to their analytics and metrics; 6) Press release title and content, either partly or in its entirety, displayed, or served to viewers in the form of impressions, either on site, on third party sites or on social media, are not included in the metrics of this report as qualified reads, as we cannot tell how many of those displays/impressions can really be considered as qualified reads (e.g. no reliable data on how long the viewer engaged with the PR content AND/OR not sure whether the viewer was actually interested in what was displayed to her/him). However, it is realistic to assume certain amount of those displays and impressions can also be considered as qualified reads for the metrics of this report. We however, cannot report how many of them qualify as real reads of the press release, hence, do not have them included in this report; 7) And in general all views and reads, having occurred on sites, places and accounts we were not made aware of upon the closure of this PR distribution report are NOT counted and included in as reads; 8) Bots, in any form, type and shape, are by default excluded from the metrics of this report, whenever detected, known and possible.
Cost per PR read: €0.038
PR title views / PR reads ratio: 7.86%
Who read*** your press release: 7,732 precisely targeted individuals living/residing in Germany (EU), France (EU), United Kingdom (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Portugal (EU), Ireland (EU), Hungary (EU), Luxembourg (EU), Slovenia (EU), Estonia (EU), Malta (EU), Russia, Switzerland, Norway, Iceland, Monaco, San Marino, Bosnia and Herzegovina, Belarus, Spain (EU), Sweden (EU) that speak/read English and are interested in and like Healthcare, Pharma & Biotech, Science, cardiology, cardiovascular, radiology, imaging, 4D, heart, MRI, pediatric, etc.



*** Read definition: For the sake of the metrics the read is considered and only counted as such, if the following conditions are met: 1) The press release page has fully been loaded in the browser and the time spent on the page by the visitor is at least 30 seconds; 2) An IP address is only counted once per 24 hours regardless how many times the same IP returned on the press release content; 3) Press release content viewed on social media sites do count as reads if and only when there are clear engagements (e.g. likes/loves, shares, tweets, re-tweets, etc.) reported by the respective social media accounts’ metrics and we have an access to and control over those accounts the event/engagement happened on in order to confirm/vitrify; 4) PR title viewed as well as PR title + excerpts viewed, either on the site or on social media accounts and third party sites and places, do NOT count as reads for the purpose of this report; 5) In general and by default press release reads are always more than what we can duly report in our press release distribution reports as we CANNOT gather data for press release content views, reads, shares, mentions, references, etc., on third party sites, social media accounts, private emails and communications (messengers, etc.) that are beyond our control and we have no access to their analytics and metrics; 6) Press release title and content, either partly or in its entirety, displayed, or served to viewers in the form of impressions, either on site, on third party sites or on social media, are not included in the metrics of this report as qualified reads, as we cannot tell how many of those displays/impressions can really be considered as qualified reads (e.g. no reliable data on how long the viewer engaged with the PR content AND/OR not sure whether the viewer was actually interested in what was displayed to her/him). However, it is realistic to assume certain amount of those displays and impressions can also be considered as qualified reads for the metrics of this report. We however, cannot report how many of them qualify as real reads of the press release, hence, do not have them included in this report; 7) And in general all views and reads, having occurred on sites, places and accounts we were not made aware of upon the closure of this PR distribution report are NOT counted and included in as reads; 8) Bots, in any form, type and shape, are by default excluded from the metrics of this report, whenever detected, known and possible.

PR shares: 18
PR likes: 73
PR G+: N/A
PR LinkedIn: 0
PR tweets/re-tweets/likes: 91
PR Pinterest: 3
PR Flipboard: 4
PR reactions / comments:
EuropaWire, Search engines, news, Blogosphere, social media, etc.
1

* Please note that PR reactions and comments may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR reactions and comments, if any, may be included in future updates on this PR distribution report.
PR mentions:
Third party mentions online as a result of your press release on EuropaWire.
1

* Please note that PR mentions may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR mentions, if any, may be included in future updates on this PR distribution report.
INSIGHTS…
PR insights, analyses, rates, averages, conclusions, etc.
Budget vs. target:
Reads vs. target:
Engagement vs. target:
Reach vs. budget:
Reads vs. budget:
Engagement vs. budget:
Reads vs. reach:
Engagement vs. reads:
Engagement vs. reach:
Language vs. target:
Reads vs. language:
Engagement vs. language:
Title vs. audience:
Title vs. target:
Reads vs. title:
EXTEND…
Extend PR distribution campaing to increase reach and engagement, etc.
Extend PR campaign & reach: Based on the PR distribution budget you choose from below, we’ll extend your existing PR distribution campaign for the same press release by using the same settings, preferences, targeting options, etc. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.



-END-
GENERAL NOTES:

Should you have any questions about this report, please contact us at info@europawire.eu.Many of the figures, numbers and values included in the PR distribution report above are not final. The current PR distribution report only covers the active period of your PR distribution campaign, which on itself depends on the PR distribution budget employed. Many of the numbers above are highly likely to increase and change over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

Please note that while this PR distribution report is not behind secure page, it is not publicly accessible and unless you give the URL (the web address) away for other people to see it, there is no other way for somebody else to find it out on the Web. No sensitive, private or financial information, if ever made available to us, will ever be published in this report section.

The information in this PR distribution report was factually accurate on the date of its last update (date shown above). This PR distribution report remains on EuropaWire website for historical purposes only. EuropaWire assumes no duty to update the information to reflect subsequent developments beyond the period of the active PR distribution campaign. Readers should not rely upon the information in this PR distribution report as current or accurate after date it was last updated on.

To have an easy and quick access to this report page for further references, please consider bookmarking it.

Thank you for releasing via EuropaWire.

Editorial Staff
EuropaWire